Life sciences news
-
V-Bio Ventures raises additional capital to support young biotech companies
Thursday January 27th 2022
Read more
-
Galapagos appoints Paul Stoffels as Chief Executive Officer
Thursday January 27th 2022
Read more
-
Biotalys appoints Kwizda Agro as formulator of its protein-based biocontrols
Thursday January 27th 2022
Read more
-
Pre-existing immune cells can predict early response to hepatitis B vaccine
Tuesday January 25th 2022
Read more
-
ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer
Tuesday January 25th 2022
Read more
-
Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes
Tuesday January 25th 2022
Read more
-
Biotalys achieves breakthrough in protein expression increasing commercial potential for its first biofungicide Evoca
Tuesday January 25th 2022
Read more
-
BIMZELX[®] (bimekizumab) approved in Japan for the treatment of plaque psoriasis, generalized pustular psoriasis and psoriatic erythroderma
Monday January 24th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis
Friday January 21st 2022
Read more
-
Cerba Healthcare enters agreement to acquire Viroclinics-DDL
Thursday January 20th 2022
Read more
-
Ann Van Gysel wordt CEO van flanders.healthTech
Thursday January 20th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
